cyclosporine has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, A; Attia, S; Delgado-Esteban, M; Detaille, D; El-Mir, MY; Fontaine, E; Guigas, B; Leverve, X; R-Villanueva, G | 1 |
| al Ayafi, H; al Jumah, M; Awada, A; Dehoux, E | 1 |
2 other study(ies) available for cyclosporine and Diabetic Neuropathies
| Article | Year |
|---|---|
Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cerebral Cortex; Cyclosporine; Cytochromes c; Diabetic Neuropathies; Enzyme Inhibitors; Etoposide; Hypoglycemic Agents; Membrane Potential, Mitochondrial; Metformin; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar | 2008 |
[Rapidly evolving diabetic mononeuritis multiplex. Favorable outcome after immunosuppressive treatment].
Topics: Adrenal Cortex Hormones; Cranial Nerve Diseases; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mononeuropathies; Treatment Outcome | 2001 |